ID: ALA452728

Max Phase: Preclinical

Molecular Formula: C16H12BrNO2

Molecular Weight: 330.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2[nH]c(-c3cc(Br)ccc3O)cc(=O)c2c1

Standard InChI:  InChI=1S/C16H12BrNO2/c1-9-2-4-13-11(6-9)16(20)8-14(18-13)12-7-10(17)3-5-15(12)19/h2-8,19H,1H3,(H,18,20)

Standard InChI Key:  NYRFXWGBTPDDKD-UHFFFAOYSA-N

Associated Targets(non-human)

GABA A receptor alpha-5/beta-3/gamma-2 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GABA receptor alpha-3 subunit 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GABA A receptor alpha-2/beta-2/gamma-2 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GABA-A receptor; alpha-1/beta-2/gamma-2 554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.18Molecular Weight (Monoisotopic): 329.0051AlogP: 3.97#Rotatable Bonds: 1
Polar Surface Area: 53.09Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.35CX Basic pKa: 0.42CX LogP: 4.23CX LogD: 4.18
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.71Np Likeness Score: -0.06

References

1. Nilsson J, Nielsen EØ, Liljefors T, Nielsen M, Sterner O..  (2008)  Azaflavones compared to flavones as ligands to the benzodiazepine binding site of brain GABA(A) receptors.,  18  (21): [PMID:18851913] [10.1016/j.bmcl.2008.09.092]

Source